Order Article Reprints

Mingot-Castellano M-E, Reguera-Ortega JL, Zafra Torres D, Hernani R, Lopez-Godino O, Guerreiro M, Herrero B, López-Corral L, Luna A, Gonzalez-Pinedo L, et al. Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients. Journal of Clinical Medicine. 2024; 13(17):5117. https://doi.org/10.3390/jcm13175117

Mingot-Castellano, Maria-Eva, Juan Luis Reguera-Ortega, Denis Zafra Torres, Rafael Hernani, Oriana Lopez-Godino, Manuel Guerreiro, Blanca Herrero, Lucia López-Corral, Alejandro Luna, Lesli Gonzalez-Pinedo, and et al. 2024. "Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients" Journal of Clinical Medicine 13, no. 17: 5117. https://doi.org/10.3390/jcm13175117

Mingot-Castellano, M.-E., Reguera-Ortega, J. L., Zafra Torres, D., Hernani, R., Lopez-Godino, O., Guerreiro, M., Herrero, B., López-Corral, L., Luna, A., Gonzalez-Pinedo, L., Chinea-Rodriguez, A., Africa-Martín, A., Bailen, R., Martinez-Cibrian, N., Balsalobre, P., Filaferro, S., Alonso-Saladrigues, A., Barba, P., Perez-Martinez, A., ... on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy (GETH-TC). (2024). Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients. Journal of Clinical Medicine, 13(17), 5117. https://doi.org/10.3390/jcm13175117